Focus Group Interview Study on Patient Experiences and Satisfaction

Patient Satisfaction Clinical Trial

— RT_Focus  

Official title:

Quality Improvement Actions on the Radiotherapy Ward: Focus Group Interview Study on Patient Experiences and Satisfaction

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04625842
• Other study ID #: 2020-087
• Status: Recruiting
• Phase: N/A
• Start date: September 1, 2020
• Est. completion date: December 1, 2021

Study information

• Verified date: November 2020
• Source: Universitair Ziekenhuis Brussel
• Contact: Mark De Ridder, MD, PhD
• Phone: 024776144
• Email: mark.deridder[@]uzbrussel.be
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

In order to improve quality of care at the department, the investigators will perform a focus group interview study with patients and family members. They will perform 6 (3 in the French, and 3 in the Dutch language) focus group interviews with patients and 6 (3 in the French, and 3 in the Dutch language) with family members.

Description:

In order to improve quality of care at the department, the investigators will perform a focus group interview study with patients and family members. They will perform 6 (3 in the French, and 3 in the Dutch language) focus group interviews with patients and 6 (3 in the French, and 3 in the Dutch language) with family members. Following research questions will be answered: - What elements of care (ie infrastructure, interpersonal contact, information, communication) are good to the opinion of patients and family members? - What elements of care can be improved? - What are priorities in improvement of the care for patients and families? - What actions could possibly be taken in order to improve the care for future patients? Because the radiotherapy ward exists of 3 clusters, one per type of treatment conducted, the investigators will perform 6 focus group interviews with patients (3 in the French, and 3 in the Dutch language) and 6 focus group interviews with family members (3 in the French, and 3 in the Dutch language). Investigators will collect sex, main diagnosis (of patients), age and nationality of all participants at the beginning of each focus group interview. They will transcribe all interviews verbatim and analyze them in Nvivo software as provided by the VUB. Participant characteristics will be analyzed by descriptive statistics.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 96
• Est. completion date: December 1, 2021
• Est. primary completion date: September 1, 2021
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion criteria for patients:

• Patients (18+) who were treated for cancer, receiving radiotherapy, and followed thereafter in the UZ Brussel
• Dutch and French speaking
• Start date of treatment max 6 months before inclusion
• Estimated sample size: 5-8 x 6 patients

Inclusion criteria for family members:

• All family members (+18) of patients who were treated for cancer, receiving radiotherapy, and followed thereafter in the UZ Brussel
• Dutch and French speaking
• Start date of treatment of patient max 6 months before inclusion
• Estimated sample size: 5-8 x 6 family members

Related Conditions & MeSH terms

• Patient Preference
• Patient Satisfaction

Intervention

Other:
• Focus group interview
Group interview with patients who received radiation treatment

Locations

Country	Name	City	State
Belgium	UZ Brussel	Brussel

Sponsors (1)

Lead Sponsor	Collaborator
Universitair Ziekenhuis Brussel

Country where clinical trial is conducted

Belgium, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Quality of care	To identify elements of care that need improvement by using open ended interview questions and interaction between different participants	immediately after treatment
Primary	Problem solving	To identify solutions for problems in care by using open ended interview questions and interaction between different participants	immediately after treatment